维普中文期刊产品整合服务
60篇 您的检索式:作者名="HEROLD KC"
    题名 作者 年代 出处 被引量
1Regulation of C-C chemokine production by routine T cells by CD28/B7 costimulation显示文摘Herold KC Lu J Rulifson I 1997J Immunol1997,159,:1
2Beta-cell mass and type 1 diabetes:going, going, gone? 显示文摘Akirav E Kushner JA Herold KC 2008Diabetes2008,57,11:1
3Regulation of cytokine production during development of autoimmune diabetes 显示文摘Herold KC Vezys V Sun Q 1996Immunol1996,156,9:1
4CD28/B7 costimulation regulates autoimmune diabetes induced with multiple low doses of streptozotocin显示文摘Herold KC Vezys V Koons A 1997J Immunol1997,158,2:1
5Anti-CD3 monoclonal antibody in new-type I diabetes mellitus显示文摘Herold KC Hagopian W Auger JA N Engl J Med0,346,22:1
6Regulation of cytokine production during development of autoimmution diabetes induced with multiple low doses of streptozocin显示文摘Herold KC Vezys V Vikyora D 1996J Immonol1996,156,:1
7Type 1 diabetes:translating mechanistic observations into effective clinical outcomes显示文摘Herold KC Vignali DA Cooke A 2013Nat Rev Immunol2013,13,4:1
8Regulation of cytokine production during development of autoimmune diabetes显示文摘Herold KC Vezys V Sun Q 1996J immunol1996,156,9:1
9CD28/B7 regulation of Th1 and Th2 subsets in the development of autoimmune diabetes显示文摘Lenschow DJ Herold KC Rhee L 1996Immunity1996,5,3:1
10Regulation of cytokine production during development of auto immune diabetes显示文摘Herold KC VezysV Sun Q 1996J Immunol1996,156,9:1
11CD28/B7 regulation of Thl and Th2 subsets in the development of autoimmune diabetes 显示文摘Lenschow DJ Herold KC Rhee L 1996Immunity1996,5,3:1
12Regulation of cytokine production during development of autoimmution diabetes induced with multiple low doses of stregtozocin显示文摘Herold KC Vezys V Vikyora D 1996J Immonol1996,156,:1
13Alterations in lymphocyte subpopulations in type 1 (insulin-dependent) diabetes mellitus:exploration of possible mechanisms and relationships to autoimmune phenomena显示文摘Herold KC Huen A Gould L 0,,:1
14In creased T cell proliferative responses to islet antigens identify clinical responders to anti-CD20 monoclonal antibody( rituximab) therapy in type 1 diabetes显示文摘HEROLD KC PESCOVITZ MD MCGEE P 2011Journal of immunology2011,187,4:1
15Prevention of autoim- mune diabetes with nonactivating anti-CD3 monoclonal antibody显示文摘Herold KC Bluestone JA Montag AG 1992Diabetes1992,41,:1
16Immunomodulatory therapy to pre- serve pancreatic beta-cell function in type 1 diabetes 显示文摘Waldron-Lynch F Herold KC 2011Nat Rev Drug Discov2011,10,6:1
17The spatiotemporal form of urban growth: measurement, analysis and modeling显示文摘Herold M Goldstein NC Clarke KC 2003Remote sensing of Envlronment2003,86,3:1
18Regulation of cytokine production during development of autoimmune diabetes显示文摘 Vezys V Sun Q 1996J Immunol1996,156,9:1
19Anti-CD3 monoclonal antibody in new-onset type 1 diabetesmellitus显示文摘Herold KC Hagopian W Auger JA 0,,22:1
20Teplizumab(anti-CD3 mAb)treatment preserves C-peptide responses in patients with new-onset type 1 diabetes in a randomized controlled trial:Metabolic and immunologic features at baseline identify a subgroup of responders显示文摘Herold KC Gitelman SE Ehlers MR 0,,11:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费